… was conducted at a tertiary hospital. Patients with metastatic NSCLC and PD-L1 ≥50% treated with pembrolizumab monotherapy in first-…
NSCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning NSCLC
189 articles · page 12 of 16…Background Many patients with non-small cell lung cancer (NSCLC) have tumours that are either refractory or develop resi…
…y reshaped the treatment paradigm for resectable non-small cell lung cancer (NSCLC), challenging long-held surgical boundaries and redefini…
…nce Group (RTTQA). Patients with locally advanced or metastatic NSCLC, who are candidates for high-dose palliative RT, before or afte…
…cal Oncology treatment guidelines and permit broad inclusion of NSCLC patients, ensuring ‘real-world’ representativeness. The study u…
…ween cancer cells and CAFs and impairs T-cell functionality. In NSCLC tissues, hMENA high CAFs associate with TGF-β and regulatory T-…
…igand 1 (PD-L1) expression and tumor mutational burden (TMB) in non-small cell lung cancer (NSCLC), and its potential impact on responses to immune checkp…
…) for lung cancer, nine (10.0%) for leukaemia, eight (8.9%) for urothelial carcinoma, and six (6.7%) for breast cancer ( table 1, online supplementa…
…ected lung nodules, potentially leading to earlier diagnoses of lung cancer, particularly non-small cell lung cancer (NSCLC).Patients and m…
… complete response (pCR) and major pathologic response (MPR) in non-small cell lung cancer (NSCLC) patients receiving neoadjuvant chemotherapy combined wi…